Cargando…
A Review of Adverse Outcomes Following Intravenous Morphine Usage for Pain Relief in Acute Coronary Syndrome
Chest pain in acute coronary syndrome (ACS) unresponsive to nitrates is routinely treated by intravenous (IV) morphine. In the past two decades, several studies have emerged, suggesting poorer outcomes in patients receiving this treatment; however, morphine remains the drug of choice for these patie...
Autores principales: | Chen, Annie, Shariati, Farimah, Chan, Tiffany, Lebowitz, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435004/ https://www.ncbi.nlm.nih.gov/pubmed/30937227 http://dx.doi.org/10.7759/cureus.3246 |
Ejemplares similares
-
Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review
por: de Alencar Neto, José Nunes
Publicado: (2018) -
Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial
por: Niezgoda, Piotr, et al.
Publicado: (2022) -
The Intravenous Drug User with a Big Heart
por: Bhagat, Abhishek, et al.
Publicado: (2018) -
Limitations of Coronary Computed Tomography Angiography in Predicting Acute Coronary Syndrome in a Low to Intermediate-risk Patient with Chest Pain
por: Zaghloul, Ahmed, et al.
Publicado: (2018) -
Acute-on-Chronic Pattern of Isolated Upper Back Pain in a Patient With Acute Coronary Syndrome
por: Harada, Yukinori, et al.
Publicado: (2023)